Firebrick Pharma’s Nasodine Expands With Guardian Health & Beauty In Singapore
Nasodine will launch in Singapore in January 2025, available exclusively at Guardian pharmacies for 12 months.
Nasodine, a product by Firebrick Pharma, will soon be available at all 121 Guardian Health & Beauty retail pharmacies across Singapore. Guardian, one of the country's largest pharmacy chains, has secured an exclusive distribution agreement for Nasodine for 12 months. The launch of Nasodine is set for January 2025. The locations also include Guardian’s six prime outlets at Changi Airport.
This partnership marks a key milestone for Firebrick, developing Nasodine's growth from online sales to being actively promoted. The collaboration will aid in recommending physical retail locations. This initiative complements the ongoing marketing efforts targeting doctors and hospitals, which are being carried out in partnership with Innorini Life Sciences. With these combined strategies, significant sales growth is expected to lift in 2025.
My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.
Altro da Pharma News
Tutti gli articoli →
Medicus Pharma presenta all’FDA il protocollo di fase 2b/3 per Teverelix
Fresenius Kabi Riceve una Lettera di Richiamo dalla FDA dopo Fallimenti nelle Indagini sul Processo Asettico presso lo Stabilimento di Melrose Park
Discussion